Names and Identifiers

• • L-Glutamic acid,N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methyl-d3-amino]benzoyl]- (9CI)
  • Methotrexate-d3
  • Methotrexate-d3 Heptaglutamate
  • Methotrexate-D3 solution
  • Methotrexate-d
  • HY-14519S
  • MS-28347
  • L-Glutamic acid,N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methyl-d3-amino]benzoyl]-(9ci)
  • DTXSID90962981
  • 432545-63-6
  • Methotrexate-D? (100?g/mL in Methanol with 1% 0.1N NaOH)
  • CS-0109156
  • N-(4-{[(4-Amino-2-imino-2,3-dihydropteridin-6-yl)methyl][(~2~H_3_)methyl]amino}benzoyl)glutamic acid
  • (2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-(trideuteriomethyl)amino]benzoyl]amino]pentanedioic acid
  • Methotrexate-d3, Technical Grade 85per cent
  • 1ST10175
  • DB-266048
  • N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methyl-d3-amino]benzoyl]-l-glutamic acid
  • Methotrexate D3
  • Methotrexate-D3; L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methyl-d3-amino]benzoyl]-; N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methyl-d3-amino]benzoyl]-L-glutamic acid
  • +expand
• • Inchi： 1S/C20H22N8O5/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27)/t13-/m0/s1/i1D3
  • InChI Key： FBOZXECLQNJBKD-FUPFOCIHSA-N
  • SMILES： OC([C@H](CCC(=O)O)NC(C1C=CC(=CC=1)N(C([2H])([2H])[2H])CC1C=NC2=C(C(N)=NC(N)=N2)N=1)=O)=O

Computed Properties

Experimental Properties